Please upgrade your browser.
We are pleased to have the opportunity to present additional analyses from our Phase 2 clinical trial of tivozanib in patients with renal cell cancer, as well as data from a Phase 1 clinical trial of AV-299 in collaboration with Merck . . .
Morphology, Attenuation, Size, and Structure (MASS) Criteria: Assessing Response and Predicting Clinical Outcome in Metastatic Renal Cell Carcinoma on Antiangiogenic Targeted Therapy
The objective of our study was to evaluate response assessment and predict clinical outcome in patients with metastatic renal cell carcinoma (RCC) receiving antiangiogenic targeted therapy. Target lesions were assessed on routine contrast-enhanced CT (CECT) images obtained during the portal venous phase using new response criteria.
The purpose of this article is to discuss the history of, indications and rationale for, and approach to imaging-guided percutaneous renal biopsies.
RCC ipsilateral recurrence risk after NSS is significantly associated with tumour size . . .
Eighth Annual Penn State Uplifting Athletes "Lift For Life" Set for July 9 to Benefit the Kidney Cancer Association
Nittany Lion Football Student-Athletes Have Raised Nearly $400,000 in Initial Seven Years
Identification of prognostic genomic markers in patients with localized clear cell renal cell carcinoma (ccRCC)
Tumor gene expression may impact prognosis following surgery for early stage ccRCC. Genomic analysis may also aid in understanding disease biology.
This novel immunotherapy has demonstrated antitumor activity in multiple tumor types (metastatic melanoma, renal cell cancer and non-Hodgkin's lymphoma) as a single agent and in combination with other therapies.
Long-term sorafenib safety profile in > 700 patients with renal cell carcinoma treated for 12 to 42 months.
Redectane(R) Meets Both Endpoints Specificity And Sensitivity With Superiority Over CT In Its Pivotal Phase III Trial
The aim of the Phase III-REDECT study was to determine whether the combination of REDECTANE® with positron emission tomography (PET) and computer tomography (CT) versus the standard use of CT alone could improve the diagnosis of renal masses. Sensitivity and specificity were the defined endpoints of the study.
Leptomeningeal Carcinomatosis From Renal Cell Cancer: Treatment Attempt With Radiation And Sunitinib
This case illustrates important issues around both biological behaviour and treatment approaches in metastatic renal cell cancer.
|Powered by NeonCRM|